The tariff classification of Sirolimus Tablets in dosage form, from India
Issued January 28, 2022 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 3004.20.0060
Headings: 3004
Product description
Sirolimus, imported in 0.5 mg, 1 mg, and 2 mg tablets, is a naturally occurring antibiotic and an immunosuppressant drug. It is used to prevent rejection in organ transplantation, treat lymphangioleiomyomatosis, and treat adults with perivascular epithelioid cell tumor (PeComa).
CBP rationale
The applicable subheading for the Sirolimus Tablets in dosage form will be 3004.20.0060, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other, containing antibiotics: Other: Other.
Full text
N323547 January 28, 2022 CLA-2-30:OT:RR:NC:N3:138 CATEGORY: Classification TARIFF NO.: 3004.20.0060 Mrs. Rhona M. Keeler NorthStar Healthcare 3300 Cork Airport Business Park Kinsale Road, Cork T12 XN72 Ireland RE: The tariff classification of Sirolimus Tablets in dosage form, from India Dear Mrs. Keeler: In your letter dated January 6, 2022, you requested a tariff classification ruling. Sirolimus, imported in 0.5 mg, 1 mg, and 2 mg tablets, is a naturally occurring antibiotic and an immunosuppressant drug. It is used to prevent rejection in organ transplantation, treat lymphangioleiomyomatosis, and treat adults with perivascular epithelioid cell tumor (PeComa). The applicable subheading for the Sirolimus Tablets in dosage form will be 3004.20.0060, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other, containing antibiotics: Other: Other.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on the World Wide Web at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected]. Sincerely, Steven A. Mack Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Clindamycin Palmitate Oral Solution in dosage form, from India
The tariff classification of Vancomycin Hydrochloride Injection in dosage form, from China
The tariff classification of Daptomycin Injection in dosage form, from China
The tariff classification of Micafungin Sodium for Injection in dosage form, from Malta
The tariff classification of Doxycycline Hyclate Injection in dosage form, from Macao
The tariff classification and country of origin of Doxorubicin Hydrochloride Liposome Injection in dosage form
The tariff classification of Vancomycin Hydrochloride for Injection in dosage form, from China
The tariff classification of Bacitracin Zinc Ointment and Zinc Oxide Ointment 20% imported in retail packs from India
The tariff classification of Clindamycin Phosphate 1% Lotion in dosage form, from Canada.
The tariff classification of Clindamycin Phosphate 1% Lotion in dosage form, from Spain
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →